NCT03255642View on ClinicalTrials.gov

Efficacy and Safety of Melatonin and Clonazepam for IRBD

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 9, 2017

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
REM Sleep Behavior Disorder
Interventions
DRUG

Melatonin 2mg

4 weeks of 2mg prolonged release melatonin (Circadin)

DRUG

ClonazePAM 0.5 MG

4 weeks of 0.5mg clonazepam (Rivotril)

Trial Locations (1)

05269

Kyung Hee University Hospital at Gangdong, Seoul

All Listed Sponsors
lead

Kyung Hee University Hospital at Gangdong

OTHER

NCT03255642 - Efficacy and Safety of Melatonin and Clonazepam for IRBD | Biotech Hunter | Biotech Hunter